Molecules/MOXETUMOMAB PASUDOTOX

MOXETUMOMAB PASUDOTOX

Molecular Identity

Antibody drug conjugateApprovedFirst approved 2018

Mechanism of action: CD22 binding agent

Molecular Formula

0.00

Molecular Weight

g/mol

CAT-8015HA-22HA22LumoxitiMoxetumomab pasudotoxMOXETUMOMAB PASUDOTOXMOXETUMOMAB PASUDOTOX TDFKMOXETUMOMAB PASUDOTOX-TDFK

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to MOXETUMOMAB PASUDOTOX

Loading drug network...